S142 Outcomes of Crohn’s Disease in Females: A Population-Based Study

treatment of UC, as it indicates complete healing of the intestinal mucosa and is associated with better long-term results. Di ff erences were observed in the types of remission achieved with di ff erent therapeutic options, in fl iximab and 5-ASA were the treatments most frequently associated with deep remission, while certolizumab and adalimumab were more common in biochemical and histological remission. It is important to note sample size which was relatively small. In conclusion, this study provides strong evidence that histological remission is achievable in patients with ulcerative colitis. Theseresults supporttheimportanceof histologicalremissionas atherapeuticgoal, asit isassociated with signi fi cant clinical improvement and more favorable long-term outcomes.